The efficacy of ado-trastuzumab emtansine in patients with HER-2-aberrant non-small cell lung cancer.

Xia, Y; Huang, X; Jin, R; Li, W; Shen, HH

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):